J. Tortochaux

4.6k total citations · 3 hit papers
38 papers, 3.2k citations indexed

About

J. Tortochaux is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, J. Tortochaux has authored 38 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Otorhinolaryngology, 20 papers in Pulmonary and Respiratory Medicine and 12 papers in Surgery. Recurrent topics in J. Tortochaux's work include Head and Neck Cancer Studies (24 papers), Lung Cancer Treatments and Mutations (10 papers) and Lung Cancer Diagnosis and Treatment (6 papers). J. Tortochaux is often cited by papers focused on Head and Neck Cancer Studies (24 papers), Lung Cancer Treatments and Mutations (10 papers) and Lung Cancer Diagnosis and Treatment (6 papers). J. Tortochaux collaborates with scholars based in France, United States and Belgium. J. Tortochaux's co-authors include C. Sire, M. Alfonsi, É. Bardet, G. Calais, B. Rhein, Philippe Bergerot, T. Germain, P. Oudinot, P. Garaud and Philippe B. Bertrand and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

J. Tortochaux

37 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma

1999 842 citations G. Calais, M. Alfonsi et al. JNCI Journal of the National Cancer Institute profile →
Final Results of the 94–01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial Comparing Radiotherapy Alone With Concomitant Radiochemotherapy in Advanced-Stage Oropharynx Carcinoma

2003 673 citations Fabrice Denis, P. Garaud et al. profile →
Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx Preservation

2009 369 citations Y. Pointreau, S. Chapet et al. JNCI Journal of the National Cancer Institute profile →

Peers

Countries citing papers authored by J. Tortochaux

Since Specialization

Citations

This map shows the geographic impact of J. Tortochaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Tortochaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Tortochaux more than expected).

Fields of papers citing papers by J. Tortochaux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Tortochaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Tortochaux. The network helps show where J. Tortochaux may publish in the future.

Co-authorship network of co-authors of J. Tortochaux

This figure shows the co-authorship network connecting the top 25 collaborators of J. Tortochaux. A scholar is included among the top collaborators of J. Tortochaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Tortochaux. J. Tortochaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: Results of a GORTEC randomized trial 2011 ·Radiotherapy and Oncology ·Jean Bourhis, M. Lapeyre, J. Tortochaux, Antoine Lusinchi, (unknown), (unknown), L. Geoffrois, C. Domenge, Pierre Verrelle, P. Wibault, François Janot, Stéphane Temam, Pierre Blanchard, Yungan Tao, Anne Aupérin	18
2	Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent 2011 ·Radiotherapy and Oncology ·J. Tortochaux, Yungan Tao, Elodie Tournay, M. Lapeyre, F. Lesaunier, É. Bardet, François Janot, Antoine Lusinchi, E Benhamou, P. Bontemps, P. Maingon, G. Calais, Nicolas Daly‐Schveitzer, Pierre Verrelle, Jean Bourhis	65
3	Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx Preservation breakdown → 2009 ·JNCI Journal of the National Cancer Institute ·Y. Pointreau, (unknown), S. Chapet, C. Sire, C. Tuchais, J. Tortochaux, Sandrine Faivre, (unknown), M. Alfonsi, (unknown)	369
4	Achieving Higher Pathological Complete Response Rates in HER-2–Positive Patients With Induction Chemotherapy Without Trastuzumab in Operable Breast Cancer 2007 ·The Oncologist ·Frédérique Penault‐Llorca, Catherine Abrial, Marie‐Ange Mouret‐Reynier, (unknown), Xavier Durando, Marianne Leheurteur, Pierre Gimbergues, J. Tortochaux, Hervé Curé, P. Chollet	7
5	5500 ORAL Induction chemotherapy for larynx preservation. Updated results of the GORTEC 2000–01 randomized trial comparing docetaxel + cisplatinum + fluorouracil (TPF) versus cisplatinum + fluorouracil (PF) 2007 ·European Journal of Cancer Supplements ·G. Calais, Y. Pointreau, M. Alfonsi, C. Sire, C. Tuchais, J. Tortochaux, S. Guérif	5
6	Premiers résultats de l'essai de phase III GORTEC 2000-01 comparant deux schémas de chimiothérapie d'induction par cisplatine et 5-fluoro-uracile avec ou sans docetaxel dans le but de préserver le larynx 2006 ·Cancer/Radiothérapie ·Y. Pointreau, M. Alfonsi, C. Sire, C. Tuchais, J. Tortochaux, Jean Bourhis, (unknown), (unknown), (unknown)	1
7	Phase III multicenter randomized study of concurrent twice-a-day radiotherapy with and without cisplatin-5FU (BiRCF) in unresectable pharyngeal carcinoma. 24 months results (FNCLCC-GORTEC) 2004 ·International Journal of Radiation OncologyBiologyPhysics ·René‐Jean Bensadoun, Karen Bénézery, A. Ramaioli, Nicolas Magné, C. Lemanski, J. Tortochaux, S. Bourdin, O. Dassonville, G. Milano, M. Schneider, G. Calais, F Démard	1
8	Concomitant radiochemotherapy or accelerated radiotherapy: Analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC) 2004 ·Seminars in Oncology ·Jean Bourhis, G. Calais, M. Lapeyre, J. Tortochaux, M. Alfonsi, C. Sire, É. Bardet, M. Rives, Philippe Bergerot, B. Rhein, (unknown)	31
9	[Targeting of epidermal growth factor receptor and applications in ORL cancer]. 2003 ·PubMed ·J. Tortochaux, (unknown), Christine Rolhion, Jean Bourhis	1
10	Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial 2003 ·International Journal of Radiation OncologyBiologyPhysics ·G. Calais, É. Bardet, C. Sire, M. Alfonsi, Jean Bourhis, B. Rhein, J. Tortochaux, (unknown), H. Auvray, P. Garaud	83
11	Tumeurs mixtes müllériennes de l’endomètre. À propos de quatre cas développés sous tamoxifène 2003 ·Gynécologie Obstétrique & Fertilité ·G. Le Bouëdec, F Penault–Llorca, M de Latour, J. Tortochaux, J Dauplat	3
12	Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems 2002 ·International Journal of Radiation OncologyBiologyPhysics ·Fabrice Denis, P. Garaud, É. Bardet, M. Alfonsi, C. Sire, T. Germain, Philippe Bergerot, B. Rhein, J. Tortochaux, P. Oudinot, G. Calais	170
13	Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma. final results of the 94-01 GORTEC randomized study 2001 ·International Journal of Radiation OncologyBiologyPhysics ·G. Calais, M. Alfonsi, É. Bardet, C. Sire, T. Germain, Cristiane Decat Bergerot, B. Rhein, J. Tortochaux, P. Oudinot, A. Favre	9
14	Result of two randomized trials comparing nolatrexed (Thymitaq™) versus methotrexate in patients with recurrent head and neck cancer 2001 ·Annals of Oncology ·Xavier Pivot, Scott Wadler, C. Kelly, Robert L. Ruxer, J. Tortochaux, Jordan C. Stern, D Belpomme, Yves Humblet, C. Domenge, Neil J. Clendeninn, A. E. Johnston, C A Penning, M. Schneider	24
15	Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma breakdown → 1999 ·JNCI Journal of the National Cancer Institute ·G. Calais, M. Alfonsi, É. Bardet, C. Sire, T. Germain, Philippe Bergerot, B. Rhein, J. Tortochaux, P. Oudinot, Philippe B. Bertrand	842
16	Cancer du sein bilatéral après maladie de Hodgkin. Particularités clinico-histologiques et possibilités thérapeutiques: analyse de 13 cas 1997 ·Cancer/Radiothérapie ·B. Cutuli, Anne de la Rochefordière, F. Dhermain, Christian Borel, Y Graïc, B. De Lafontan, (unknown), H. Mignotte, (unknown), J. Tortochaux, T. Nguyen, P. Bey, (unknown), R. Arriagada	16
17	Breast cancer in patients treated for hodgkin’s disease: clinical and pathological analysis of 76 cases in 63 patients 1997 ·European Journal of Cancer ·(unknown), F. Dhermain, Christian Borel, (unknown), Y Graïc, B. De Lafontan, (unknown), H. Mignotte, (unknown), J. Tortochaux, Thomas Nguyen, Pierre Bey, (unknown), Michel Velten, R. Arriagada	26
18	High-Dose Therapy and Autologous Bone Marrow Transplantation in First Complete or Partial Remission for Poor Prognosis Hodgkin's Disease 1996 ·Leukemia & lymphoma ·Joël Fleury, Michel Legros, Philippe Colombat, Hervé Curé, Philippe Travade, J. Tortochaux, C Dionet, P. Chollet, Claude Linassier, (unknown), Didier Blaise, Patrice Viens, D Maraninchi, R Plagne	15
19	Male breast cancer: Results of the treatments and prognostic factors in 397 cases 1995 ·European Journal of Cancer ·B. Cutuli, M Lacroze, Jean-Marie Dilhuydy, (unknown), B. De Lafontan, C. Marchal, M. Resbeut, Y Graïc, F. Campana, (unknown), C. De Gislain, J. Tortochaux, J.C. Cuillere, M. Reme-Saumon, Thomas Nguyen, F. Lesaunier, (unknown), Érick Gamelin, Michel Héry, J Berlié	164
20	The Hematopoietic Stem Cell Transplantation in Hodgkin's Disease: Questions and Controversies 1994 ·Leukemia & lymphoma ·Joël Fleury, Michel Legros, (unknown), J. Tortochaux, (unknown), C Dionet, Philippe Travade, Ernest Bélembaogo, (unknown), Fabrice Kwiatkowski, P. Chollet, R Plagne	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact